G1 Therapeutics to Participate in the 41st Annual J.P. Morgan Conference

Rhea-AI Summary

G1 Therapeutics, Inc. (Nasdaq: GTHX) announced that CEO Jack Bailey will present at the 41^st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 1:30 PM PST. This event showcases the company's commitment to developing innovative cancer therapies, including its first product, COSELA® (trilaciclib). The presentation will be accessible via webcast on their official website. G1 Therapeutics focuses on improving the lives of cancer patients through a robust clinical pipeline targeting various solid tumors.

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that on January 11, 2023, at 1:30 PM PST, G1’s Chief Executive Officer Jack Bailey will provide a corporate presentation during the 41^st Annual J.P. Morgan Healthcare Conference.

The webcast of the event will be accessible on the Events & Presentations page of http://www.g1therapeutics.com.

About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). G1 has a deep clinical pipeline and is executing a tumor-agnostic development plan evaluating trilaciclib in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

G1 Therapeutics® and the G1 Therapeutics logo and COSELA® and the COSELA logo are trademarks of G1 Therapeutics, Inc

Contacts:
Will Roberts
Vice President, Investor Relations & Corporate Communications
919-907-1944
wroberts@g1therapeutics.com

FAQ

When is G1 Therapeutics' presentation at the J.P. Morgan Healthcare Conference?

G1 Therapeutics' presentation is scheduled for January 11, 2023, at 1:30 PM PST.

Who is presenting on behalf of G1 Therapeutics at the conference?

CEO Jack Bailey will present on behalf of G1 Therapeutics at the conference.

Where can I watch G1 Therapeutics' conference presentation?

The presentation can be watched via webcast on G1 Therapeutics' official website.

What is the focus of G1 Therapeutics?

G1 Therapeutics focuses on developing therapies for cancer treatment, including its product COSELA®.

What is the stock symbol for G1 Therapeutics?

The stock symbol for G1 Therapeutics is GTHX.